These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 36538603)
1. Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A English CJ; Lohning AE; Mayr HL; Jones M; Reidlinger DP Biofactors; 2023 Mar; 49(2):457-471. PubMed ID: 36538603 [TBL] [Abstract][Full Text] [Related]
2. Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A English CJ; Jones M; Lohning AE; Mayr HL; MacLaughlin H; Reidlinger DP Eur J Nutr; 2024 Mar; 63(2):445-460. PubMed ID: 38063929 [TBL] [Abstract][Full Text] [Related]
3. The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study. English CJ; Lohning AE; Mayr HL; Jones M; MacLaughlin H; Reidlinger DP Nutr Metab (Lond); 2023 Sep; 20(1):38. PubMed ID: 37700354 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults. Detopoulou P; Nomikos T; Fragopoulou E; Panagiotakos DB; Pitsavos C; Stefanadis C; Antonopoulou S Lipids Health Dis; 2009 Jun; 8():19. PubMed ID: 19500354 [TBL] [Abstract][Full Text] [Related]
5. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study. da Silva IT; Timm Ade S; Damasceno NR Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection. Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269 [TBL] [Abstract][Full Text] [Related]
7. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk]. Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750 [TBL] [Abstract][Full Text] [Related]
8. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors]. Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) bound to LDL and HDL. Tellis CC; Tselepis AD Curr Pharm Des; 2014; 20(40):6256-69. PubMed ID: 24953389 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia. Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of Lipoprotein-Associated Phospholipase A Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060 [TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease. Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512 [TBL] [Abstract][Full Text] [Related]
14. Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers. Detopoulou P; Nomikos T; Fragopoulou E; Antonopoulou S Curr Vasc Pharmacol; 2021; 19(6):663-672. PubMed ID: 34182909 [TBL] [Abstract][Full Text] [Related]
15. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. Jiang Z; Fehrenbach ML; Ravaioli G; Kokalari B; Redai IG; Sheardown SA; Wilson S; Macphee C; Haczku A Respir Res; 2012 Nov; 13(1):100. PubMed ID: 23140447 [TBL] [Abstract][Full Text] [Related]
16. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Tellis CC; Tselepis AD Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes. Cai R; Huang R; Han J; Sun H; Sun J; Xia W; Tian S; Dong X; Shen Y; Wang S Sci Rep; 2017 Sep; 7(1):12311. PubMed ID: 28951620 [TBL] [Abstract][Full Text] [Related]
18. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677 [TBL] [Abstract][Full Text] [Related]
19. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors]. Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228 [TBL] [Abstract][Full Text] [Related]
20. Association between the serum lipoprotein-associated phospholipase A Dong L; Tong J; Fan S Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]